Cargando…

Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study

OBJECTIVE: To analyze the relationship between tumor size and metastatic site in stage IV NSCLC patients. METHODS: A total of 40,196 stage IV NSCLC patients from 2010 to 2015 were screened by SEER database. Chi-square test was used to compare the characteristics of clinical variables. At the same ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Qinge, Fan, Yanling, Guo, Jun, Han, Xiao, Wang, Haiyong, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790223/
https://www.ncbi.nlm.nih.gov/pubmed/31616594
http://dx.doi.org/10.7717/peerj.7822
_version_ 1783458757686067200
author Shan, Qinge
Fan, Yanling
Guo, Jun
Han, Xiao
Wang, Haiyong
Wang, Zhehai
author_facet Shan, Qinge
Fan, Yanling
Guo, Jun
Han, Xiao
Wang, Haiyong
Wang, Zhehai
author_sort Shan, Qinge
collection PubMed
description OBJECTIVE: To analyze the relationship between tumor size and metastatic site in stage IV NSCLC patients. METHODS: A total of 40,196 stage IV NSCLC patients from 2010 to 2015 were screened by SEER database. Chi-square test was used to compare the characteristics of clinical variables. At the same time, multivariate Logistic regression analysis was used to evaluate the relationship between tumor size and organ metastasis. RESULTS: Regardless of tumor size, the proportion of bone metastasis and lung metastasis was higher and similar in patients with squamous cell carcinoma, while in patients with adenocarcinoma, bone metastasis accounted for the highest proportion. We found that whether the metastatic site was bone, brain, liver or lung, the proportion of patients with a tumor size of 3–7 cm was the highest. Multivariate regression analysis demonstrated that patients with a tumor size of 3–7 cm and a tumor size ≥7 cm were more likely to develop brain metastasis and lung metastasis compared with patients with a tumor size ≤3 cm (all P < 0.001), which meant the larger the tumor, the greater the risk of brain or lung metastasis. At the same time, the results indicated that patients with a tumor size of 3–7 cm had a tendency to develop liver metastasis (P = 0.004), while the statistical significance was not found for patients with a tumor size ≥7 cm (P = 0.524). The results also revealed that patients with a tumor size of 3–7cm had no significant difference to develop bone metastasis (P = 0.116), while the statistical significance was found for patients with a tumor size ≥7 cm (P < 0.001). CONCLUSIONS: There was statistical significance between tumor size and metastatic site in patients with stage IV NSCLC. For brain or lung metastasis, the larger the tumor, the higher the risk of brain or lung metastasis. For liver metastasis, patients with a tumor size of 3–7 cm were more prone to develop liver metastasis. For bone metastasis, patients with a tumor size ≥7 cm were more likely to have bone metastasis.
format Online
Article
Text
id pubmed-6790223
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-67902232019-10-15 Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study Shan, Qinge Fan, Yanling Guo, Jun Han, Xiao Wang, Haiyong Wang, Zhehai PeerJ Global Health OBJECTIVE: To analyze the relationship between tumor size and metastatic site in stage IV NSCLC patients. METHODS: A total of 40,196 stage IV NSCLC patients from 2010 to 2015 were screened by SEER database. Chi-square test was used to compare the characteristics of clinical variables. At the same time, multivariate Logistic regression analysis was used to evaluate the relationship between tumor size and organ metastasis. RESULTS: Regardless of tumor size, the proportion of bone metastasis and lung metastasis was higher and similar in patients with squamous cell carcinoma, while in patients with adenocarcinoma, bone metastasis accounted for the highest proportion. We found that whether the metastatic site was bone, brain, liver or lung, the proportion of patients with a tumor size of 3–7 cm was the highest. Multivariate regression analysis demonstrated that patients with a tumor size of 3–7 cm and a tumor size ≥7 cm were more likely to develop brain metastasis and lung metastasis compared with patients with a tumor size ≤3 cm (all P < 0.001), which meant the larger the tumor, the greater the risk of brain or lung metastasis. At the same time, the results indicated that patients with a tumor size of 3–7 cm had a tendency to develop liver metastasis (P = 0.004), while the statistical significance was not found for patients with a tumor size ≥7 cm (P = 0.524). The results also revealed that patients with a tumor size of 3–7cm had no significant difference to develop bone metastasis (P = 0.116), while the statistical significance was found for patients with a tumor size ≥7 cm (P < 0.001). CONCLUSIONS: There was statistical significance between tumor size and metastatic site in patients with stage IV NSCLC. For brain or lung metastasis, the larger the tumor, the higher the risk of brain or lung metastasis. For liver metastasis, patients with a tumor size of 3–7 cm were more prone to develop liver metastasis. For bone metastasis, patients with a tumor size ≥7 cm were more likely to have bone metastasis. PeerJ Inc. 2019-10-10 /pmc/articles/PMC6790223/ /pubmed/31616594 http://dx.doi.org/10.7717/peerj.7822 Text en ©2019 Shan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Global Health
Shan, Qinge
Fan, Yanling
Guo, Jun
Han, Xiao
Wang, Haiyong
Wang, Zhehai
Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
title Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
title_full Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
title_fullStr Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
title_full_unstemmed Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
title_short Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
title_sort relationship between tumor size and metastatic site in patients with stage iv non-small cell lung cancer: a large seer-based study
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790223/
https://www.ncbi.nlm.nih.gov/pubmed/31616594
http://dx.doi.org/10.7717/peerj.7822
work_keys_str_mv AT shanqinge relationshipbetweentumorsizeandmetastaticsiteinpatientswithstageivnonsmallcelllungcanceralargeseerbasedstudy
AT fanyanling relationshipbetweentumorsizeandmetastaticsiteinpatientswithstageivnonsmallcelllungcanceralargeseerbasedstudy
AT guojun relationshipbetweentumorsizeandmetastaticsiteinpatientswithstageivnonsmallcelllungcanceralargeseerbasedstudy
AT hanxiao relationshipbetweentumorsizeandmetastaticsiteinpatientswithstageivnonsmallcelllungcanceralargeseerbasedstudy
AT wanghaiyong relationshipbetweentumorsizeandmetastaticsiteinpatientswithstageivnonsmallcelllungcanceralargeseerbasedstudy
AT wangzhehai relationshipbetweentumorsizeandmetastaticsiteinpatientswithstageivnonsmallcelllungcanceralargeseerbasedstudy